Articles related to Psychiatry

Explore the FDA-cleared Modius Stress, offering groundbreaking ease in managing generalized anxiety with daily 30-minute sessions, showing significant reductions in GAD-7 scores in international clinical trials.

The proposed shift of marijuana to a Schedule III drug highlights its recognized medical applications and potential to treat conditions like anxiety and chronic pain, offering a safer alternative to traditional treatments.

Recent studies highlight that while meditation is beneficial for many, it can also lead to significant mental health challenges, including anxiety, psychosis, and depersonalization, particularly in intense meditative practices.

Among the approved SGAs for MDD, no single medication stands out as the first choice; decision-making is guided by individual patient profiles and side effect considerations.

Lithium continues to be recognized as the most reliable mood stabilizer for bipolar disorder patients with a history of mania, necessitating precise management of dosages to prevent significant side effects.

Rejoyn represents a significant advancement in the treatment of major depressive disorder, requiring prescription use and integrating brain-training exercises developed by leading mental health experts.